Implantable medical devices manufacturer Aran Biomedical has unveiled new medical textile valve covering solution, called ValvTEX, for mitral, aortic and tricuspid heart valves.
The ValvTEX technology platform was created to reduce the delivery profile of transcatheter heart valves that require a valve skirt, whilst also offering some unique advantages. The solution involves custom low-profile fabric attached onto the valve frame without the need for sutures.
Lower delivery profile is achieved by reducing the amount of fabric pleating during crimping, along with the reduction or elimination of sutures required to attach the fabric. Not only does this improve manufacturing time, but a further advantage from the attachment process is the ability to create an impermeable seal at select regions of the skirt, which can help inhibit paravalvular leakage.
Aran Biomedical CEO Peter Mulrooney said: “Aran Biomedical’s focused investment in medical textile & coating technologies has enabled our skilled engineers to deliver a proprietary medical textile valve covering solution to support the exciting fields of Mitral, Aortic and Tricuspid heart valve replacement.”
Considering the increased interest in transcatheter product development to treat a greater range of structural heart conditions, the ValvTEX platform technology is ideally positioned to support next generation devices.
Aran Biomedical Teoranta is a Galway based company that specialises in customised medical implant product solutions, with expertise in medical textiles, advanced braiding, elastomeric coating and encapsulation, as well as resorbable implants.
The company offers a full-service solution, from design and development, to full-scale manufacturing of key components and finished devices, for world leading Tier medical device companies who seek a trusted partner to help realise their product development needs.
Source: Company Press Release